Related Experiment Video

Updated: Jun 11, 2026

Simple Establishment of a Vascularized Osteogenic Bone Marrow Niche Using Pre-Cast Poly(ethylene Glycol) (PEG) Hydrogels in an Imaging Microplate
10:32

Simple Establishment of a Vascularized Osteogenic Bone Marrow Niche Using Pre-Cast Poly(ethylene Glycol) (PEG) Hydrogels in an Imaging Microplate

Published on: May 19, 2023

Epidermal growth factor and bone morphogenetic proteins upregulate osteoblast proliferation and osteoblastic markers

Claude Laflamme1, Sèverine Curt, Mahmoud Rouabhia

  • 1Groupe de recherche en écologie buccale, Faculté de médecine dentaire, Pavillon de médecine dentaire, Université Laval, Québec, Canada G1K 7P4.

Archives of Oral Biology
|July 15, 2010
PubMed
Abstract

Insights

Epidermal growth factor (EGF) promotes early osteoblast growth but inhibits later bone mineralization. EGF may synergize with bone morphogenetic proteins (BMPs) for cell proliferation, but not differentiation.

Area of Science:

  • Cell Biology
  • Biochemistry
  • Regenerative Medicine

Background:

  • Osteogenic differentiation is crucial for bone regeneration.
  • Bone morphogenetic proteins (BMPs) are key regulators of osteogenesis.
  • Epidermal growth factor (EGF) role in osteogenesis requires further elucidation.

Purpose of the Study:

  • To investigate the in vitro osteogenic activity of EGF alone and in combination with BMP2 and BMP7.
  • To assess the effects of EGF and BMPs on osteoblast proliferation, gene expression, and mineralization.

Main Methods:

  • SaOS-2 cells were cultured with EGF and BMPs.
  • Cell proliferation assessed via MTT assay.
  • Gene expression (Runx2, ALP, OC) analyzed by RT-PCR and ELISA.
  • Mineralization evaluated using Alizarin Red staining.

Main Results:

  • EGF stimulated osteoblast proliferation, potentially synergizing with BMPs.
  • EGF upregulated Runx2 mRNA but downregulated ALP and OC mRNA expression.
  • EGF inhibited bone nodule formation and mineralization, even with BMPs present.

Conclusions:

  • EGF promotes early-stage osteoblast proliferation and specific marker expression.
  • EGF's role appears limited in later stages of osteoblast differentiation and mineralization.
  • EGF may have a complex, context-dependent role in osteogenesis when combined with BMPs.

More Related Videos

Peptides from Phage Display Library Modulate Gene Expression in Mesenchymal Cells and Potentiate Osteogenesis in Unicortical Bone Defects07:53

Peptides from Phage Display Library Modulate Gene Expression in Mesenchymal Cells and Potentiate Osteogenesis in Unicortical Bone Defects

Published on: December 10, 2010

Related Concept Videos

Hormones and Bone Tissue01:17

Hormones and Bone Tissue

The endocrine system produces and secretes hormones, which interact with the skeletal system. These hormones control bone growth, maintain bone once it is formed, and remodel it.
Hormones That Influence Osteoblasts and/or Maintain the Matrix
Several hormones are necessary for controlling bone growth and maintaining the bone matrix. The pituitary gland secretes growth hormone (GH), which, as its name implies, controls bone growth. This happens in several ways: first, it triggers chondrocyte...
TGF - β Signaling Pathway01:16

TGF - β Signaling Pathway

The TGF-β signaling pathway regulates cell growth, differentiation, adhesion, motility, and development. TGF-β ligands that induce TGF-β signaling are synthesized in their latent form. Several proteases or cell surface receptors such as integrins act upon the latent form, releasing the active ligand. There are three types of mammalian TGF-βs: (TGF-β1, TGF-β2, and TGF-β3) that bind as homodimers or heterodimers to TGF-β receptors. The TGF-β receptors are of three kinds RI, RII, and RIII. The RI...
Osteoclasts in Bone Remodeling01:31

Osteoclasts in Bone Remodeling

Osteoclasts are cells responsible for bone resorption and remodeling. They originate from hematopoietic progenitor cells present in the bone marrow. Numerous progenitor cells fuse to form multinucleated cells, each with 10-20 nuclei. A single osteoclast has a diameter of 150 to 200 µM. These cells have ruffled borders that break down the underlying bone tissue and release minerals such as calcium into the blood in bone resorption. Osteoclasts cling to bones with their ruffled edges during bone...
Regulation of Angiogenesis and Blood Supply01:24

Regulation of Angiogenesis and Blood Supply

Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits.  Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl hydroxylase and factor...
Mitogens and the Cell Cycle02:38

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
Bone Remodeling01:40

Bone Remodeling

Bone remodeling is a continuous and balanced process of bone resorption by osteoclasts and bone formation by osteoblasts. In adults, it helps maintain bone mass and calcium homeostasis. While mechanical stress can stimulate turnover as part of the normal maintenance and reparative process, several hormones also regulate bone remodeling.